Cartesian Therapeutics Inc (RNAC)

27.01 -1.51 (-5.29%) USD  |  NASDAQ  |  Jun 28, 16:00
26.60 -0.41 (-1.52%) After-Hours: 20:00
More

Cartesian Therapeutics EPS Estimates for Next Fiscal Year

EPS Estimates for Next Fiscal Year Chart

View EPS Estimates for Next Fiscal Year for RNAC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Estimates for Next Fiscal Year Data

View and export this data back to 2024. Upgrade now.
Date Value
June 04, 2024 --
May 30, 2024 --
Date Value
April 23, 2024 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Next Fiscal Year Range, Past 5 Years

Upgrade
Minimum
Apr 23 2024
Upgrade
Maximum
Jun 04 2024
Upgrade
Average
Upgrade
Median
May 30 2024

EPS Estimates for Next Fiscal Year Benchmarks

Marinus Pharmaceuticals Inc Upgrade
Adial Pharmaceuticals Inc Upgrade
Poseida Therapeutics Inc Upgrade
Viracta Therapeutics Inc Upgrade
Biomea Fusion Inc Upgrade

EPS Estimates for Next Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade